Incannex Healthcare IXHL
NASDAQ IXHL
$3.39 -0.05 (-1.45%)
At close: Aug 20, 2026 · 2:04 PM UTC

Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026)

Incannex Healthcare (IXHL) posted Income towards Parent Company of -$3.9 million for Q1 2026, up 40.45% sequentially from -$6.5 million in Q4 2025, and up 2.14% YoY from -$3.8 million in Q1 2025.

Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026) Analysis & Trends

Incannex Healthcare has reported Income towards Parent Company for 5 years, with the latest figure at -$3.9 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
  • Income towards Parent Company advanced to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$726000.0 in Q3 2023 and troughed at -$31.6 million in Q2 2025.
  • A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 646.56% in 2024, then jumped 34.21% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$2.9 million in 2022, then slumped by 79.61% to -$5.2 million in 2023, then decreased by 12.46% to -$5.9 million in 2024, then dropped by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Incannex Healthcare 41.74 Mn 41.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.88 Mn
Dec 31, 2025 -6.52 Mn
Sep 30, 2025 -6.41 Mn
Jun 30, 2025 -31.60 Mn
Mar 31, 2025 -3.97 Mn
Dec 31, 2024 -5.89 Mn
Sep 30, 2024 -5.42 Mn
Jun 30, 2024 -6.43 Mn
Mar 31, 2024 -6.03 Mn
Dec 31, 2023 -5.24 Mn
Sep 30, 2023 -726,000.00
Jun 30, 2023 -4.17 Mn
Mar 31, 2023 -3.57 Mn
Dec 31, 2022 -2.92 Mn